Efficacy and Safety of Ciclesonide Nasal Spray for the Treatment of Seasonal Allergic Rhinitis

Efficacy and Safety of Ciclesonide Nasal Spray for the Treatment of Seasonal Allergic Rhinitis

In this phase III, double-blind, placebo-controlled trial, patients with SAR (age >= 12 years) were randomized to receive intranasal CIC 200 μg (n = 164) or placebo (n = 163) once daily for 28 days.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2006-02, Vol.117 (2), p.S168-S168
Hauptverfasser: Ratner, P.H., van Bavel, J.H., Darken, P., Hall, N., Shah, T., Wingertzahn, M.A.
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this phase III, double-blind, placebo-controlled trial, patients with SAR (age >= 12 years) were randomized to receive intranasal CIC 200 μg (n = 164) or placebo (n = 163) once daily for 28 days.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2005.12.668